M. Okawa et al., VITAMIN-B-12 TREATMENT FOR DELAYED SLEEP PHASE SYNDROME - A MULTICENTER DOUBLE-BLIND-STUDY, PSYCHIATRY AND CLINICAL NEUROSCIENCES, 51(5), 1997, pp. 275-279
The active form of vitamin B-12 (methylcobalamin) has been reported to
be effective on sleep-wake rhythm disorders. Previous studies, howeve
r, were performed under open trial, and the effect of vitamin B-12 has
not been properly evaluated. The aim of this double-blind study was t
o investigate the efficacy of methylcobalamin on delayed sleep phase s
yndrome (DSPS). Methylcobalamin (3 mg/day) or placebo was administered
for 4 weeks. The subjects were 50 patients with DSPS aged 13-55 years
(26.5 +/- 1.3), 27 of whom received the active drug while 23 received
the placebo. No significant differences were observed between the 2 g
roups in subjective evaluations of mood or drowsiness during the dayti
me or in night sleep by sleep-log evaluation. These results indicate t
hat 3 mg methylcobalamin administered over 4 weeks is not an effective
treatment for DSPS.